Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

RTTNews | 356 days ago
Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.

Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.

This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.

read more
Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews | 850 days ago
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved  In Nigeria

Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria

Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews | 1004 days ago
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews | 1104 days ago
TSX Settles Roughly Flat

TSX Settles Roughly Flat

The Canadian stock market ended flat on Friday, amid uncertainty on US-Canada trade deal even as July 9 deadline set by the US President for tariff agreement is fast approaching.
RTTNews | 1 day ago
Swiss Market Ends Slightly Down

Swiss Market Ends Slightly Down

After languishing in negative territory till a little before the final hour of the day's trading session, the Switzerland market managed to emerge into positive zone on Friday but failed to hold firm and eventually settled with a marginal loss.
RTTNews | 1 day ago
TSX Up Marginally After Posting New Record High

TSX Up Marginally After Posting New Record High

The Canadian market is up marginally a little past noon on Friday with investors largely making cautious moves on weak private sector activity report, and amid uncertainty about Trump administration's tariff moves.
RTTNews | 1 day ago